
Which Herbs Help Lower Blood Pressure? - Jordan News
Monitor your blood pressure regularly if using herbs for treatment to prevent dangerous drops.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Jordan News
3 days ago
- Jordan News
Which Herbs Help Lower Blood Pressure? - Jordan News
Which Herbs Help Lower Blood Pressure? Lifestyle changes are a key part of managing high blood pressure, and studies have shown that many herbs, long used in traditional medicine, offer significant cardiovascular benefits and help reduce blood pressure naturally and effectively. اضافة اعلان 1. Garlic Garlic tops the list due to its active compound allicin, which helps relax blood vessels and improve circulation—leading to lower blood pressure. Numerous studies have shown that garlic supplements, especially aged garlic extract, can significantly reduce both systolic and diastolic blood pressure. Research also indicates that garlic, whether used alone or alongside medications, may reduce the risk of heart attacks or strokes by 16% to 40%. 2. Hibiscus Often consumed as a tea, hibiscus is rich in antioxidants that help relax blood vessels and enhance blood flow. Drinking 1–3 cups daily has been shown to significantly lower blood pressure, with some studies suggesting effects comparable to mild medications. 3. Cinnamon Cinnamon contains anti-inflammatory compounds that support vessel relaxation and responsiveness. A meta-analysis found that cinnamon may reduce both systolic and diastolic pressure within just eight weeks. Ceylon cinnamon is recommended over Cassia cinnamon, which may be harmful in large quantities. 4. Holy Basil, Cardamom, and Ginger Holy Basil (Tulsi) helps relieve stress—one of the main contributors to high blood pressure. It lowers cortisol levels and soothes blood vessels. Cardamom has antioxidant and anti-inflammatory properties and acts similarly to calcium channel blockers, aiding blood flow. One study showed moderate blood pressure reduction after three months of daily intake. Ginger enhances circulation and reduces vascular spasms. Its anti-inflammatory and antioxidant qualities help lower both systolic and diastolic pressure, even in small daily amounts. 5. Turmeric, Sesame, and Flaxseeds Turmeric contains curcumin, which reduces inflammation and oxidative stress in blood vessels, supports elasticity, and improves vascular function. Some studies show a notable drop in systolic pressure with curcumin use. Sesame seeds or oil are rich in healthy fats and antioxidants. Regular use of sesame oil may enhance nitric oxide production, relaxing blood vessels and reducing blood pressure. Flaxseeds are high in omega-3s, fiber, and antioxidants. Daily consumption supports sustainable blood pressure reduction and overall heart health. They're easy to add to everyday meals. How to Include These Herbs in Your Diet Incorporating these herbs doesn't require major effort: Add fresh garlic, ginger, or basil leaves to salads, soups, or stir-fries. Drink hibiscus or ginger tea daily. Sprinkle cinnamon, flaxseeds, sesame, or ground cardamom on oatmeal, yogurt, or baked goods. For those who prefer supplements, many of these herbs are available as capsules, powders, or even healthy gummies. Choose products certified by trusted organizations like USP or NSF to ensure purity and accurate labeling. Important Precautions While these herbs have health benefits, some precautions are essential—especially when taken as supplements: Consult your doctor before starting any herbal supplement, particularly if you're on blood pressure medication, as interactions may occur. Stick to recommended dosages to avoid side effects. Pregnant or breastfeeding women should avoid most herbal remedies unless under medical supervision. Monitor your blood pressure regularly if using herbs for treatment to prevent dangerous drops.


Roya News
4 days ago
- Roya News
Weapon of starvation: 69 children dead, 620 patients lost in Gaza
The Government Media Office in Gaza has reported a devastating update on the worsening humanitarian crisis in the besieged strip. According to a statement released Friday, at least 69 children have died from malnutrition, while the total number of patients who have died due to shortages of food and medicine has reached 620. This comes amid a complete blockade by the Israeli Occupation, with no effective international intervention in place to halt what local authorities are calling a growing humanitarian catastrophe. The office revealed the following statistics highlighting the severity of the crisis: 139 days since 'Israel' closed all border crossings. 76,450 trucks carrying humanitarian aid and fuel have been denied entry. 42 community kitchens have been targeted by 'Israeli' forces. 57 aid distribution centers were struck. 121 humanitarian convoys were attacked. 877 people were killed in what the office described as 'death traps' at US- and 'Israeli'-designated aid zones. 650,000 children are now at risk of death due to hunger and malnutrition. 12,500 cancer patients face death from lack of medicine and treatment. 60,000 pregnant women are in critical danger due to insufficient medical care and nutrition. The office condemned what it described as a 'continuous crime,' holding the Israeli Occupation fully responsible, alongside its allies such as the United States, Germany, and France. It called on the international community to take immediate action to end the starvation policy, save lives, and ensure the urgent reopening of Gaza's crossings to allow the delivery of humanitarian aid.

Ammon
01-07-2025
- Ammon
Hikma Pharmaceuticals to Invest $1B in U.S. Manufacturing & R&D Capabilities
Ammon News - Hikma Pharmaceuticals will invest $1 billion by 2030 to further expand its US manufacturing and R&D capabilities. This new phase of investment will further expand Hikma's domestic capabilities to develop, produce and deliver a broad range of medicines. Hikma has operated in the US since 1991 and has spent more than $4 billion over the past 15 years to build, enhance and expand its US-based R&D and manufacturing capabilities and now has annual domestic capacity to produce more than 12 billion finished doses of essential medicines. Over this period, Hikma has provided patients with access to a wide range of generic medicines at a lower cost than branded products. The new phase of investment represents the Company's latest efforts to increase the volume of essential medicines it develops and produces across its R&D and manufacturing sites in Columbus and Cleveland, Ohio and in Cherry Hill and Dayton, New Jersey. This next phase of expansion will help to strengthen Hikma's portfolio of more than 800 medicines and increase the Company's US-based capacity to produce large volumes of high-quality and affordable medicines for American hospitals, providers and patients. 'We are proud to continue our ongoing investments in US manufacturing and R&D to better serve the needs of American patients,' said Dr. Hafrun Fridriksdottir, President, Hikma Rx. 'Hikma and our 2,300 dedicated US people are committed to supporting healthier communities nationwide by providing Americans with a steady and reliable supply of domestically produced quality medicines.'